Finance

Beta
Lists
NRXP:NASDAQ
NRX Pharmaceuticals Inc
$3.56
0.00%
(0.00) 1D
$3.58
+0.56% (+0.020)
After hours
Closed: Jun 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRXP...
Open
$3.55
High
$3.77
Low
$3.40
Mkt. cap
128.98M
Avg. vol.
1.52M
Volume
79.00
52-wk high
$5.06
52-wk low
$1.62
EPS
-$1.28
Beta
2.14
Shares outstanding
41.94M
No. of employees
29
Open
$3.55
High
$3.77
Low
$3.40
Mkt. cap
128.98M
Avg. vol.
1.52M
Volume
79.00
52-wk high
$5.06
52-wk low
$1.62
EPS
-$1.28
Beta
2.14
Shares outstanding
41.94M
No. of employees
29
News stories
From sources across the web
About NRX Pharmaceuticals Inc
CEO-
Employees29
Founded2015
HeadquartersWilmington, Delaware, United States
SectorPharmaceutical industry
Websitenrxpharma.com
Analyst ratings
Based on 4 analysts giving stock ratings to NRXP in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for NRXP in the last 3 months.
Highest
Current $3.56
$49.00 (+1,276.40%)
Average
$38.25 (+974.44%)
Lowest
$25.00 (+602.25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$45.00
+1,164%
06/25/2026
Thomas Shrader
BTIG
Buy
Maintained
$25.00
+602.2%
06/22/2026
Elemer Piros
Lucid Capital
Buy
Initiated
$49.00
+1,276.4%
05/13/2026
Jason Kolbert
D. Boral Capital
Buy
Maintained
$34.00
+855.1%
04/20/2026
Edward Woo
Ascendiant
Buy
Maintained
$48.00
+1,248.3%
12/31/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
242.00K
983.00K
1.07M
Cost of goods sold
-
97.00K
408.00K
631.00K
Cost of revenue
-
97.00K
408.00K
631.00K
Research and development expenses
987.00K
1.43M
558.00K
1.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.74M
2.81M
4.57M
3.81M
Operating expense
3.73M
4.26M
5.17M
5.18M
Total operating expenses
3.73M
4.36M
5.58M
5.82M
Operating income
-3.73M
-4.12M
-4.59M
-4.75M
Other non operating income
-8.29M
-366.00K
1.59M
3.54M
EBT including unusual items
-17.58M
-5.89M
360.00K
-1.43M
EBT excluding unusual items
-12.02M
-4.48M
-3.67M
-1.44M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.58M
-5.89M
360.00K
-1.43M
Net profit margin
-
-2,433.88%
36.62%
-133.90%
Earnings per share
-0.98
-0.51
0.18
-0.04
Interest and investment income
2.00K
2.00K
4.00K
5.00K
Interest expense
-
-
-671.00K
-233.00K
Net interest expenses
2.00K
2.00K
-667.00K
-228.00K
Depreciation and amortization charges
-
26.00K
42.00K
63.00K
EBITDA
-3.73M
-4.11M
-4.55M
-4.68M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of NRXP
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer